Warfarin Bleeding Risk - Elderly
Estimate 90 day risk of bleeding in patients on warfarin who are >65 years
This bleeding risk score was developed to guide the clinical use of warfarin in the elderly atrial fibrillation (AF) population. It uses clinical variables to predict the 90 day risk of acute bleeding event from the index AF hospitalization. Major bleeding was defined as hospital admission for either a GI hemorrhage or intracranial hemorrhage.
Theresa I. Shireman, Jonathan D. Mahnken, Patricia A. Howard, Timothy F. Kresowik, Qingjiang Hou and Edward F. Ellerbeck.